{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:05:31Z","timestamp":1781719531350,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.yebeh.2016.05.023","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T23:00:12Z","timestamp":1468623612000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial"],"prefix":"10.1016","volume":"62","author":[{"given":"Christian E.","family":"Elger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Elmoufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dedeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tennigkeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.05.023_bb0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WCO.0b013e32833735e7","article-title":"Metabolic consequences of antiepileptic drugs","volume":"23","author":"Mintzer","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1528-1167.2007.01147.x","article-title":"Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy \u2014 a prospective randomized double-blind withdrawal study","volume":"48","author":"Lossius","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isoj\u00e4rvi","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11940-005-0037-8","article-title":"Effects of treatment on endocrine function in patients with epilepsy","volume":"7","author":"Pack","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/clpt.1980.216","article-title":"Kinetics of a carbamazepine\u2013ethosuximide interaction","volume":"28","author":"Warren","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1984.tb02482.x","article-title":"A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients","volume":"18","author":"Perucca","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1157.1995.tb01045.x","article-title":"Menstrual disorders in women with epilepsy receiving carbamazepine","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1528-1157.1995.tb01011.x","article-title":"Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003088-200948050-00003","article-title":"Characterization of the time course of carbamazepine deinduction by an enzyme turnover model","volume":"48","author":"Punyawudho","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/appi.ajp.2010.09091269","article-title":"Pregabalin abuse, dependence, and withdrawal: a case report","volume":"167","author":"Grosshans","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","article-title":"Current understanding of the mechanism of action of the antiepileptic drug lacosamide","volume":"110","author":"Rogawski","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yebeh.2015.09.006","article-title":"Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials","volume":"52","author":"Biton","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"From the Commission on Classification and Terminology of the International League Against Epilepsy","volume":"22","author":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yebeh.2009.07.014","article-title":"Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study","volume":"16","author":"Lossius","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0095","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1528-1157.1995.tb01619.x","article-title":"Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00196862","article-title":"Serum sex hormone levels after replacing carbamazepine with oxcarbazepine","volume":"47","author":"Isojarvi","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2016.05.023_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2008.01966.x","article-title":"Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency","volume":"50","author":"Galimberti","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00415-010-5888-6","article-title":"Disease- and treatment-related effects on the pituitary\u2013gonadal functional axis: a study in men with epilepsy","volume":"258","author":"Bauer","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1017\/S1092852900001528","article-title":"Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones","volume":"6","author":"Morrell","year":"2001","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0120","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2073","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2011.10.001","article-title":"Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein","volume":"98","author":"Mintzer","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOL.0000000000000097","article-title":"The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy","volume":"25","author":"Soran","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0404.2007.00883.x","article-title":"Carbamazepine and risk of hypothyroidism: a prospective study","volume":"116","author":"Simko","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0140","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eiris-Pu\u00f1al","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0145","first-page":"183","article-title":"Transient hypothyroidism induced by anticonvulsant agents","volume":"35","author":"Krysiak","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.yebeh.2016.05.023_bb0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pds.3498","article-title":"Use of antiepileptic drugs and risk of hypothyroidism","volume":"22","author":"Lai","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016301081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016301081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:37:36Z","timestamp":1718696256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016301081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"alternative-id":["S1525505016301081"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.05.023","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}